Imaging in Lyme neuroborreliosis by Lindland, Elisabeth Margrete Stokke et al.
PICTORIAL REVIEW
Imaging in Lyme neuroborreliosis
Elisabeth S. Lindland1,2,3 & Anne Marit Solheim4,5 & Silje Andreassen3,6 & Else Quist-Paulsen3,7 & Randi Eikeland4,8 &
Unn Ljøstad4,5 & Åse Mygland4,5 & Ahmed Elsais9 & Gro O. Nygaard9 & Åslaug R. Lorentzen4,8 & Hanne F. Harbo3,9 &
Mona K. Beyer1,10
Received: 2 May 2018 /Revised: 25 June 2018 /Accepted: 4 July 2018 /Published online: 4 September 2018
# The Author(s) 2018
Abstract
Lyme neuroborreliosis (LNB) is a tick-borne spirochetal infection with a broad spectrum of imaging pathology. For individuals who
live in or have travelled to areas where ticks reside, LNB should be considered among differential diagnoses when clinical manifes-
tations from the nervous system occur. Radiculitis, meningitis and facial palsy are commonly encountered, while peripheral neurop-
athy, myelitis, meningoencephalitis and cerebral vasculitis are rarer manifestations of LNB. Cerebrospinal fluid (CSF) analysis and
serology are key investigations in patient workup. The primary role of imaging is to rule out other reasons for the neurological
symptoms. It is therefore important to know the diversity of possible imaging findings from the infection itself. There may be no
imaging abnormality, or findings suggestive of neuritis, meningitis, myelitis, encephalitis or vasculitis. White matter lesions are not a
prominent feature of LNB. Insight into LNB clinical presentation, laboratory test methods and spectrum of imaging pathologywill aid
in themultidisciplinary interaction that often is imperative to achieve an efficient patient workup and arrive at a correct diagnosis. This
article can educate those engaged in imaging of the nervous system and serve as a comprehensive tool in clinical cases.
Key Points
• Diagnostic criteria for LNB emphasise exclusion of an alternative cause to the clinical symptoms.
• MRI makes a crucial contribution in the diagnosis and follow-up of LNB.
• MRI may have normal findings, or show neuritis, meningitis, myelitis, encephalitis or vasculitis.
• White matter lesions are not a prominent feature of LNB.
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Introduction
Lyme borreliosis is an infection with the spirochete Borrelia
burgdorferi (Bb). It is transmitted through tick bites, and is the
most common vector-borne disease in Europe and North
America [1, 2]. Estimates of prevalence are 100-130 per
100,000 in Europe, and 20-100 cases per 100,000 people in
the United States (US) [3]. Involvement of the nervous system
is reported to occur in 10-15% of patients with borreliosis [4].
In Europe, the dominant strains are Borrelia garinii and
Borrelia afzelii, whereas Borrelia burgdorferi sensu stricto is
the only pathogen in American Lyme borreliosis [4–6].
Lyme neuroborreliosis (LNB) is an important differential
diagnosis in patients with nonspecific nervous system MRI
findings and possibility of previous exposure to tick bite. In
this article, we explain the diagnostic criteria, summarise and
discuss current knowledge of imaging and pathology in LNB
and describe the imaging findings in a spectrum from the
typical presentations (meningoradiculitis, cranial nerve in-
volvement), to less common (myelitis, peripheral neuropathy)
and rare disease courses (meningoencephalitis, vasculitis).
Disease manifestations
The clinical presentation of LNB can vary widely, partly due
to the genetic differences in spirochetal strains. Individual
variations in immunological response and the possibility of
co-infections may also explain the wide spectrum of symp-
toms that can be encountered. The skin is primarily affected,
and erythema migrans can be observed. About one third to
half of patients with LNB recall a tick bite or a rash [7, 8]. The
most common neurological manifestation of LNB in adults is
the Bannwarth syndrome with painful radiculoneuritis and
aseptic meningitis, the former is most prominent in Europe
and the latter in North America [1]. LNB with facial nerve
palsy is commonly encountered in both continents. Rarer
manifestations from the nervous system are meningoenceph-
alitis, encephalomyelitis, cerebral vasculitis and peripheral
neuropathy [6]. LNB may rarely present to the ophthalmolo-
gist with optic neuropathies and papilledema due to raised
intracranial pressure [9]. The distinction between early and
late LNB is made from duration of neurological symptoms
of less or more than 6 months, and more than 95% of cases
are classified as early disease [10]. Most LNB patients
respond well to antibiotic treatment, but some experience per-
sistent complaints [11, 12]. A definition for post-Lyme disease
syndrome has been suggested to include subjective symptoms
of fatigue, cognitive symptoms and/or widespread musculo-
skeletal pain starting within 6 months after completed treat-
ment [13]. Post-Lyme disease syndrome is not discussed in
this article.
Diagnostic criteria
The European Federation of Neurological Societies (EFNS)
established guidelines for LNB diagnosis in 2010 [10]. The
criteria for LNB diagnosis are: LNB compatible neurological
symptoms and signs with no other explanation, pleocytosis and
production of Bb specific antibodies in the cerebrospinal fluid
(CSF). Intrathecal antibody production is often expressed as a
positive Bb antibody index (AI), where measurements of anti-
body show a higher level in CSF than in serum [14]. The
European guidelines state that the condition is possible when
two out of three criteria are present, and definite when all three
criteria are met (Table 1). Direct test methods for detection ofBb,
mainly culture and polymerase chain reaction, have low sensi-
tivity and are seldom helpful in the diagnostic work-up [14].
Interpretation of serology can also be a challenge in the diagnos-
tic process, since the sensitivity is low in the early stage of infec-
tion. Further, both IgM and IgG antibodies can remain positive
several years after infection, so results may not differentiate pre-
vious exposure, reinfection or acute infection [14, 15]. American
Academy of Neurology (AAN) diagnostic criteria do not include
analysis of cerebrospinal fluid, but presence of one or more of
erythema migrans, direct proof through histopathology, microbi-
ology or polymerase chain reaction or immunologic evidence of
infection [4]. To increase specificity of serology, a two-tier ap-
proach is recommended with an initial enzyme immunoassay
followed by separate immunoglobulin Western blots if the first
step is positive [14]. Both American and European diagnostic
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criteria for LNB emphasise the exclusion of other apparent cause
to the clinical disorder [4]. Magnetic resonance imaging (MRI)
therefore makes a crucial contribution in the diagnosis and
follow-up of LNB.
Pathology
A recent study with inoculation of Bb infection in the central
nervous system (CNS) of rhesus macaques resulted in
Fig. 1 Meningoradiculitis due to Lyme neuroborreliosis (LNB) in a 73-
year-old female. She experienced periods of strong superficial abdominal
pain, reduced appetite and headache. Sagittal T2 (a) and T1 after
gadolinium-based contrast agent injection (b, c) demonstrated normal
cord parenchyma and diffuse leptomeningeal enhancement (arrows) of
spinal cord and brain stem. Cerebrospinal fluid (CSF) analysis showed
pleocytosis and intrathecal production of Borrelia burgdorferi (Bb)-
specific IgM and IgG antibodies. No leptomeningeal enhancement was
found 4 weeks after the treatment on post-contrast sagittal T1 weighted
images (d, e)
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lymphocytic neuritis and ganglionitis, and neuronal degeneration
and demyelination in the peripheral nervous system. In brainstem
andmedulla therewere lesionswith focalmalacia and nerve fibre
degeneration, and some subjects had myelitis with necrosis and
degeneration [16]. The experiment gave evidence that the nerve
injuries are mainly due to immune mediated mechanisms.
Human studies are limited, but have pointed mainly to axonal
damage in LNB mononeuropathy and plexopathy [4, 17]. The
myelitis seen in most LNB cases could be the inflammation of
radiculoneuritis extending to the spinal cord, CNS parenchymal
involvement is otherwise considered rare in LNB [4]. Bb inva-
sion into the human brain has been reported in four cases with
biopsy from MRI enhancing lesions [18–20].
Imaging in Lyme neuroborreliosis
Early imaging reports, starting with Halperin et al. in 1988 and
1989, focused on non-specific white matter changes in Lyme
encephalopathy, considered a late phase of LNB with mild
cognitive deficits [21, 22]. These and six other studies
published between 1990 and 2007 included 10-27 subjects,
and white matter lesions were found in 15-63% of the patients
[23–28]. The diagnostic criteria in these reports varied, and for
many cases would not fulfil the EFNS or AAN criteria of today.
Sequence development and higher resolution ofMRI have con-
stantly evolved with increased sensitivity of this imaging meth-
od, and knowledge of age-related white matter changes has also
changed throughout this time. Therefore, the claim that LNB
causes non-specific white matter changes should be considered
based on weak scientific evidence. In 2009 Agarwal and Sze
reported imaging data in 66 patients with LNB. Seven patients,
but also six out of the 50 healthy control subjects, had white
matter lesions, and the result suggests that white matter lesions
are not a feature of LNB. One patient had an enhancing pa-
renchymal lesion and three had meningeal or cranial nerve
enhancement [18]. Numerous case reports demonstrate that
LNB has a wide spectrum of imaging entities, including
diffuse or tumour-like affection in brain or spinal cord [19,
20, 29–34], meningeal and/or nerve enhancement [33–43],
as well as vascular affection with stroke-like presentation
[44–54] or haemorrhage [35, 55, 56]. Overlap of imaging
Fig. 2 Facial neuritis in LNBwith typical disease course in a 55-year-old
female. She suffered from back pain radiating to chest, arms, head and
neck, especially intense at night time, and after 2 weeks she also
developed bilateral facial palsy. CSF analysis showed 594 cells/mm3
(normal range 0-5/mm3) and production of Bb specific IgG and IgM
antibodies. Axial post-contrast fat suppressed T1-weighted image (a)
showed intense enhancement in the distal intracanalicular, labyrinthine
and geniculate ganglion segments of both facial nerves (arrows point to
these structures which are mentioned from medial to lateral). 3 mm
sagittal reformat (b) on the right side demonstrated the enhancement
involving the tympanic and mastoid segment, as well as the parotid
segment with the temporofacial and cervicofacial branches at the pes
anserinus included (arrows point to these structures which are
mentioned from cranial to caudal). Axial post-contrast fat suppressed
T1-weighted image showed no abnormal enhancement of facial nerves
6 months after the treatment (c)
836 Insights Imaging (2018) 9:833–844
findings between LNB and multiple sclerosis (MS) has
been discussed [1, 57], but is understudied.
There is limited knowledge of structural and functional
changes in LNB with quantitative MRI techniques. Three stud-
ies have reported structural changes, and no difference between
the patients and controls was found [23, 27, 28]. However,
these studies included a limited number of subjects and controls
(n = 6-20), so they probably lacked power to show subtle
changes. Functional studies have been conducted with PET
[58, 59] and with SPECT [26, 60–62]. These studies reported
regional hypoactivity and hypoperfusion, but were hampered
by heterogeneous study populations with non-specific symp-
toms and included individuals with uncertain diagnoses.
Larger, prospectively conducted case-control studies are needed
to learn more about imaging abnormalities in LNB.
Meningoradiculitis
The most typical manifestation of nervous system involvement
in European Lyme borreliosis is the Bannwarth syndrome with
radiculoneuritis, causing radicular pain and sometimes paresis of
Fig. 3 LNB myelitis in a 35-year
old female who presented with
pain radiating in the right arm,
neck stiffness and general
symptoms of headache, fatigue,
nausea and vomiting. T2
weighted images showed subtle
spinal cord hyperintensity, on
sagittal image (a) from C2-C5
centrally located (arrows), and on
axial T2 gradient echo image at
the C2/C3 level (b), dominant
affection adjacent to the right
anterior horn was seen (arrow).
CSF analysis showed increased
cell count as well as intrathecal
production of Bb specific IgM
and IgG antibodies. Two months
after treatment she had fully
recovered. Seven years has
passed since her symptom debut,
and there has been no further
incidence of neurological
affection
Fig. 4 Brachial plexus neuritis in
a 74-year-old woman with acute
distal right arm paresis. In the
preceding weeks she had nausea,
vomiting and weight loss, and felt
increasingly forgetful and
unsteady. A fluid-sensitive
coronal STIR sequence showed
diffusely increased signal of the
nerve bundle on the right side
(arrows) compared to the left side.
Lumbar puncture followed, and
showed cell count of 101/mm3 as
well as a positive Bb IgG antibody
index (AI)
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extremities or the abdominal wall [1, 7]. Patients often describe
nocturnal exacerbation of the pain, and location and intensity
may vary [10]. Studies report 19.5 – 29% of LNB cases to have
clinical signs of meningitis [7, 8]. Enhancement of meninges,
cranial and spinal nerves can be encountered. Images in Fig. 1
show a case of LNB with meningoradiculitis where
leptomeningeal enhancement was diffuse and widespread, and
disappeared promptly with treatment. The frequency of
leptomeningeal enhancement on MRI examination in LNB has
only been reported in the abovementioned retrospective study by
Fig. 5 LNB meningoencephalitis in a 45-year-old female who presented
with fatigue, headache, dizziness and vomiting. Neurological findings
were tremor and unsteady gait. The CSF cell count was 270 cells/mm3
and there was a positive Bb IgGAI. Post-contrast sagittal (a) and axial (b)
FLAIR images demonstrated patchy leptomeningeal enhancement over
the cerebral convexities and in the posterior fossa (arrows). There was a
hyperintense lesion in the left thalamus (arrow) on axial T2-weighted
image (c) and coronal FLAIR image (d). There was no abnormality in
the lesion on diffusion weighted images (not shown). Post-contrast axial
(e) and coronal (f) T1-weighted images showed punctate and curvilinear
uptake (arrows) in the thalamic lesion. Similar, subtle changes were
present in the right thalamus. After 2 months there was only slight
residual hyperintensity in the left thalamus (arrow) on axial FLAIR
image (g) and no sign of enhancement on post-contrast axial T1
weighted image (h). One year after treatment there were no imaging
abnormalities (i)
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Agarwal and Sze. One of 63 LNB cases with contrast enhanced
MRI examination in that study showed mild leptomeningeal
enhancement [18]. For bacterial meningitis in general, post-
contrast T1-weighted images yield a low rate of leptomeningeal
enhancement, while the use of post-contrast FLAIR sequence
increases sensitivity of MRI [63, 64]. It is also important to be
aware of the rather low specificity of meningeal enhancement
with T1-weighted images, mainly due to interpretation disturbed
by the normal enhancement in vascular structures [65].
Cranial neuritis
About 80% of cranial nerve involvement in LNB affect
facial nerves, bilaterally in 25% of the cases [4, 66]. In a
recently published retrospective evaluation of 68 LNB
patients, facial palsy was the cause for hospitalisation in
50% of the patients [8]. A study by Ogrinc et al. of 77
patients with early LNB reported facial palsy in 36% [7].
MRI can demonstrate diffuse enhancement of cranial
nerves, as shown in Fig. 2. There are no reports of
nodular enhancement. Imaging evaluation of inflamma-
tion in the facial nerve can be challenging due to the lack
of specificity concerning aetiology, in addition to normal
enhancement seen in long segments of this nerve [67]. In
the clinical setting, attention should be paid to asymmetry
or marked intensity of enhancement in the geniculate gan-
glion, tympanic or mastoid segments, while there is nor-
mally no enhancement in the cisternal, intracanalicular,
labyrinthine or parotid segments. To our knowledge, there
are no data of the diagnostic accuracy of MRI in LNB
facial neuritis. In 36 patients with idiopathic facial palsy
a high sensitivity (100%) was found in contrast enhanced
3D T1 gradient echo sequence with fat suppression, and
specificity was improved from 57 to 86% with the use of
a contrast enhanced 3D FLAIR sequence [68]. In the
workup of facial palsy, MRI can exclude a compressing
lesion, brainstem infarct, perineural tumour spread or fo-
cal lesion such as schwannoma [67]. Certain concomitant
MRI findings can be suggestive of some inflammatory
etiologies such as Guillain-Barré syndrome, multiple scle-
rosis and sarcoidosis. In most cases of facial palsy, CSF
Fig. 6 LNB encephalitis in a 40-year-old woman. She presented with
1 day history of headache, vomiting, dizziness and personality change.
The CSF cell count was 182 cells/mm3. MRI showed symmetric diffuse
and patchy T2 (a) and FLAIR (b, c) hyperintensity of inferior thalami
(arrows in a), cerebral peduncles, mesencephalon, pons (arrows in b) and
cerebellar dentate nuclei (arrows in c). There were no abnormalities on
diffusion-weighted or post-contrast images (not shown). Further clinical
and laboratory investigations revealed erythema migrans on the right
thigh and a positive CSF Bb IgG AI. Tests for TBE antibodies were
negative. She received antimicrobial treatment, and repeated MRI
8 weeks after the initial scan was normal (d–f)
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analysis is an important supplemental test that will help to
differentiate, and possibly identify, inflammatory and in-
fectious etiologies.
Myelitis
Myelitis confirmed by MRI constituted 7% of the LNB mani-
festations leading to hospitalisation in the aforementioned study
by Schwenkenbecher et al. [8]. In addition to the five cases
from that study, we have found 11 adult case reports of LNB
myelitis with abnormal MRI findings of the spinal cord sub-
stance [29, 34, 42, 69–76]. In all of them the cervical spinal
cord was affected. The majority were, like the case presented in
Fig. 3, longitudinally extensive and centrally or slightly anteri-
orly located. One case had a focal lesion at the C5 level [69],
and another multifocal cervical lesions [75]. Enhancement pat-
terns ranged from no enhancement, to nodular or diffusely ex-
tensive contrast enhancement. Also, one case report of a cervi-
cal spinal cord syrinx exists [73]. Lumbosacral myelitis and
normal MRI findings have also been reported [39, 77]. In the
setting of an acute transverse myelitis, additional findings of
nerve root or leptomeningeal enhancement can be helpful im-
aging features in differentiating LNB fromMS and other causes
of centrally located myelitis such as acute disseminated enceph-
alomyelitis and neuromyelitis optica spectrum disorders. Many
infectious myelopathies can have combined manifestations
with meningitis, radiculitis and encephalitis, among these are
varicella-zoster virus, Epstein-Barr virus, tick-borne encephali-
tis (TBE) virus and cytomegalovirus [78]. History of pain can
also be an important clue to the LNB diagnosis, but again CSF
analysis is the key supplemental test.
Peripheral neuropathy
Bannwarth syndrome with radicular pain and/or facial palsy
are typical LNB manifestations. Plexus neuritis or
mononeuritis multiplex are other peripheral manifestations,
seen in 5-10% of LNB cases [10]. This can present as a chron-
ic asymmetric neuropathy, and will in such cases usually not
have meningitis or intrathecal antibody production [79]. In
neuritis due to LNB, nonspecific findings such as increased
signal of nerve structures on fluid-sensitive sequence can be
encountered. Figure 4 shows a case of acute peripheral motor
nerve affection due to LNB brachial plexus neuritis. No symp-
toms of radiculitis preceded the motor affection in our patient,
which is untypical [29, 80]. Due to the focal or regional dis-
tribution of symptoms in such patients, MRI will commonly
supplement clinical, blood and electrodiagnostic tests, in case
nerve entrapment or a mass lesion can be revealed [81].
Encephalitis
Among the 68 patients studied by Schwenkenbecher et
al., one adult and two children were clinically classified
as acute encephalitis, and one of them had abnormal MRI
findings [8]. Non-specific MRI findings of diffuse in-
volvement of brain parenchyma are among the few case
reports mentioned earlier, and has also occasionally been
encountered in our institutions (Figs. 5 and 6). The case in
Fig. 5 has a resemblance to CLIPPERS (chronic lympho-
cytic inflammation with pontine perivascular enhance-
ment responsive to steroids), an entity thought to repre-
sent immune-mediated inflammation [82]. Interestingly, in
our patient the abnormality resolved with antibiotic treat-
ment only. Massengo et al. reported a case with similar
type of punctate and linear enhancing lesions in cerebral
and cerebellar parenchyma which responded to steroid
treatment [32]. No specific pattern of involvement for
LNB encephalitis can be identified from the few cases that
exist. Still, of note is that it seems closer to the involvement
pattern seen in rhombencephalitis, which also can present
in combination with leptomeningeal enhancement in infec-
tions such as Listeria monocytogenes and tuberculosis.
Involvement of insula, temporal lobe and limbic system,
which is typical for herpes simplex virus infection, has not
been reported in LNB [83]. We have seen cases with in-
volvement of thalami, and this was also reported in a case
of LNB encephalitis by Haene et al. [30]. Among other
conditions with acute and subacute thalamic affection are
Japanese encephalitis, acute disseminated encephalomyeli-
tis, neuro-Beςhet, venous and arterial infarctions.
Involvement of thalami, basal ganglia and cerebellum
have also been proposed to be suggestive of viral tick-
borne encephalitis [84, 85]. Tests for specific antibodies
to both Bb and TBE virus should be included in the workup
of patients with suspected encephalitis who live in or have
travelled to areas where these tick-borne infections are
endemic.
Fig. 7 LNB vasculitis in a 55-year-old womanwith strange behaviour for
3 days preceding hospital admission. She had incoherent speech and was
disorientated. CSF cell count was 213 cells/mm3 and Bb IgG AI was
positive. MRI revealed ischemic lesions of different ages in thalamus
bilaterally (a–f), right cerebral peduncle (g–i) and right occipital cortex
(not shown). Axial T2-weighted images (a, d, g), diffusion weighted
B1000 images (b, e, h) and ADC maps (c, f, i) demonstrated the
lesions. In contrast to the hypointense lesions on ADC maps in the
thalami (arrows in c and f) consistent with cytotoxic edema in recent
infarcts, the lesion in the right cerebral peduncle was hyperintense on
both B1000 image (arrow in h) and ADC map (arrow in i), consistent
with vasogenic edema and a more advanced stage of ischemic lesion.
5 mm MIP coronal (j) and axial (k) reformats of CT angiography
examination demonstrated several short stenotic segments of both
posterior cereberal arteries (arrows), most pronounced on the right side
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Cerebral vasculitis
LNB vasculitis is presumed to be caused by the inflam-
matory response to the spirochetal infection [16]. A
German study calculated a 0.3% chance of cerebral vas-
culitis in Lyme borreliosis, and there may be an affinity
for involvement of the posterior cerebral circulation in
LNB vasculitis [44, 86]. Imaging is necessary to recog-
nise this type of complication (Fig. 7). Diffusion weighted
imaging can identify the restricted diffusion typical for
acute and subacute ischemic lesions, a finding which has
not been reported or seen in our experience in LNB en-
cephalitic lesions. Angiographic examinations can demon-
strate irregularities of the vessel lumen with occlusion or
segmental narrowing or dilatation. Such findings support
a diagnosis of vasculitis, and can be attributed to LNB in
case of fulfilled diagnostic criteria as described previous-
ly. It is important for radiologists and clinicians to be
aware of LNB as a possible cause for stroke and vasculitis
in patients exposed to ticks.
Conclusion
Non-specific imaging findings are a constant challenge to ra-
diologists. Insight into clinical disease courses and laboratory
test methods will aid in the multidisciplinary interaction that
often is imperative to achieve an efficient patient workup and
arrive at a correct diagnosis. This is especially true in LNB,
where a wide spectrum of neurological, and sometimes gen-
eral and cognitive symptoms can be encountered, as well as
diverse imaging pathology from neuritis to meningitis, en-
cephalitis and vasculitis. The primary role of imaging is to
look for other causes to explain the clinical symptoms. This
article can educate those engaged in imaging of the nervous
system and serve as a comprehensive tool when LNB is in
question.
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